Last update 23 Jan 2025

Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Thiamine Disulfide/Pyridoxine Hydrochloride/Hydroxocobalamin Acetate, チアミンジスルフィド/ピリドキシン塩酸塩/ヒドロキソコバラミン酢酸塩, 维生素B1/维生素B6/维生素B12
+ [8]
Target-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseHemic and Lymphatic Diseases+ [1]
Active Indication
AnemiaArthralgiaDiabetes Mellitus+ [4]
Inactive Indication-
Originator Organization
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
Active Organization
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.Tsuruhara Pharmaceutical Co. Ltd.Koa Isei Co., Ltd.Koa Isei Co., Ltd.
+ [1]
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (27 Apr 1967),
Avitaminosis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H34N8O4S2
InChIKeyGFEGEDUIIYDMOX-UHFFFAOYSA-N
CAS Registry67-16-3
View All Structures (3)

Related

100 Clinical Results associated with Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
100 Translational Medicine associated with Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
100 Patents (Medical) associated with Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
1
Literatures (Medical) associated with Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin
01 Jun 1981Rinsho hoshasen. Clinical radiography
[The effect of Neolamin 3B to the anemia of cancer patients (author's transl)].
100 Deals associated with Thiamine Disulfide/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Arthralgia
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Diabetes Mellitus
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Myalgia
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Neuralgia
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Neuritis
JP
Nippon Kayaku Co., Ltd.Nippon Kayaku Co., Ltd.
22 Jun 1967
Avitaminosis
JP
Viatris Healthcare GK
27 Apr 1967
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free